Chemoenzymatic Synthesis and Protein Engineering Enable Efficient, Scalable Production of Teleocidin Derivatives
Angewandte Chemie International Edition · 08.09.2025 · 64 (37)
DOI: 10.1002/anie.202509083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 26.07.2025. Verfasst von Shuo Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, Hubei Province, P.R. China. Hauptthemen laut MEDLINE: Protein Engineering, Indole Alkaloids, Lyngbya Toxins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Monoterpenoid indole alkaloids (MIAs), a class of bioactive natural products, are highly valued in drug development for their unique pharmacological activities. Teleocidins, known for activating protein kinase C (PKC), are particularly promising but challenging to synthesize due to their structural complexity. Traditional methods often rely on heavy metals and yield low amounts, while biosynthetic approaches face efficiency issues. Our study developed an efficient chemoenzymatic route to produce 13 teleocidin B compounds and derivatives at scale. To overcome enzymatic reaction bottlenecks, we engineered the critical enzyme TleB by fusing a reductase module to create a self‐sufficient P450 system, boosting indolactam V production to 868.8 mg L −1 . Additionally, we established a dual‐cell factory co‐expressing engineered hMAT2A‐TleD and TleB/TleC enzymes, enabling the first fully enzymatic synthesis of teleocidin B isomers with a total yield of 714.7 mg L −1 . Chemical modifications further expanded the library with five novel indolactam V and two teleocidin A1 derivatives. Fermentation confirmed the recombinant Escherichia coli system's scalability, producing 430 mg indolactam V, 170 mg teleocidin A1, and 300 mg teleocidin B isomers. This work not only establishes a sustainable platform for teleocidin synthesis but also addresses efficiency and scalability challenges in complex natural product synthesis, paving the way for practical applications of bioactive compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, Hubei Province, P.R. China.
- Hubei Vocational College of Bio-Technology, Wuhan, Hubei Province, P.R. China.
- School of Cyber Space Security, Huazhong University of Science and Technology, Wuhan, Hubei Province, P.R. China.
- Wuhan University Shenzhen Research Institute, Wuhan University, Shenzhen, Guangdong Province, P.R. China.
ORCID-Profile: Heng Song
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Science and Technology Program
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zheng, S., Yang, Z., Long, X., Ge, X., Zhang, Z., Feng, Y., Li, Y., Gu, B., Long, Y., Yang, X., Xu, R., & Song, H. (2025). Chemoenzymatic Synthesis and Protein Engineering Enable Efficient, Scalable Production of Teleocidin Derivatives. Angewandte Chemie International Edition, 64(37). https://doi.org/10.1002/anie.202509083
Vancouver
Zheng S, Yang Z, Long X, Ge X, Zhang Z, Feng Y, et al. Chemoenzymatic Synthesis and Protein Engineering Enable Efficient, Scalable Production of Teleocidin Derivatives. Angewandte Chemie International Edition. 2025;64(37). doi:10.1002/anie.202509083
BibTeX
@article{Zheng2025,
author = {Zheng, Shuo and Yang, Zixuan and Long, Xiang and Ge, Xinying and Zhang, Zhiqin and Feng, Yinyin and Li, Yangyizhuo and Gu, Bo and Long, Yan and Yang, Xuanliang and Xu, Rui and Song, Heng},
title = {Chemoenzymatic Synthesis and Protein Engineering Enable Efficient, Scalable Production of Teleocidin Derivatives},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {37},
doi = {10.1002/anie.202509083}
}
EUVIMED